To the best of the authors' knowledge, this clinical trial is the first that assesses the effect of vitamin D supplementation on these oxidative stress biomarkers (PON-1, TAC, and 8-isoprostan) in children with ADHD. Here, PON1 is linked to attention deficit-hyperactivity disorder.